Huiyong Zhang

Yangzhou 225125, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Effects and health risk assessments of different spray disinfectants on microbial aerosols in chicken houses.

Effects and health risk assessments of different spray disinfectants on microbial aerosols in chicken houses.

Journal: Poultry science

Published: January 03, 2025

VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response.

VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response.

Journal: Molecular immunology

Published: August 05, 2023

Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement.

Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement.

Journal: Cell death discovery

Published: May 05, 2023

VEGF165b Mutant Promotes the Apoptosis of Murine Breast Cancer Cells Induced by Paclitaxel by Inducing Tumor Vessel Maturation.

VEGF165b Mutant Promotes the Apoptosis of Murine Breast Cancer Cells Induced by Paclitaxel by Inducing Tumor Vessel Maturation.

Journal: Protein and peptide letters

Published: April 10, 2023

Chimeric antigen receptor-modified macrophages trigger systemic anti-tumour immunity.

Chimeric antigen receptor-modified macrophages trigger systemic anti-tumour immunity.

Journal: The Journal of pathology

Published: May 14, 2020

VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway.

VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway.

Journal: Molecular immunology

Published: April 29, 2020

VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice.

VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice.

Journal: Molecular immunology

Published: March 05, 2020

A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis.

A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis.

Journal: Molecular immunology

Published: February 19, 2020

A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell.

A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell.

Journal: Biochemical and biophysical research communications

Published: December 02, 2019

Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells.

Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells.

Journal: Molecular immunology

Published: May 27, 2019

Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response.

Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response.

Journal: Vaccine

Published: March 22, 2018

VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model.

VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model.

Journal: Journal of biotechnology

Published: January 26, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026